Gadopiclenol
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Gadopiclenol, sold under the brand name Elucirem among others, is a contrast agent used with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in the central nervous system and in the body. Gadopiclenol is a paramagnetic macrocyclic non-ionic complex of gadolinium. Gadopiclenol was approved for medical use in the United States in September 2022, and in the European Union in December 2023.
Gadopiclenol, sold under the brand name Elucirem among others, is a contrast agent used with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in the central nervous system and in the body. Gadopiclenol is a paramagnetic macrocyclic non-ionic complex of gadolinium. Gadopiclenol was approved for medical use in the United States in September 2022, and in the European Union in December 2023.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1378612264 under CC BY-SA 4.0; modifications have been made.